<root>
	<PMID Version="1">25480496</PMID>
	<Summary>
		1: Pigazzi M, Manara E, Buldini B, Beqiri V, Bisio V, Tregnago C, Rondelli R,Masetti R, Putti MC, Fagioli F, Rizzari C, Pession A, Locatelli F, Basso G.Minimal residual disease monitored after induction therapy by RQ-PCR cancontribute to tailor treatment of patients with t(8;21) RUNX1-RUNX1T1rearrangement. Haematologica. 2015 Mar;100(3):e99-101. doi:10.3324/haematol.2014.114579. Epub 2014 Dec 5. PubMed PMID: 25480496; PubMedCentral PMCID: PMC4349288.
	</Summary>
	<MeshHeadingList>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D000970">Antineoplastic Agents</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="Y" UI="D002891">Chromosomes, Human, Pair 21</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="Y" UI="D002898">Chromosomes, Human, Pair 8</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D050676">Core Binding Factor Alpha 2 Subunit</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D003561">Cytarabine</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D016903">Drug Monitoring</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D005047">Etoposide</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D015255">Idarubicin</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D060828">Induction Chemotherapy</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D007231">Infant, Newborn</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D015470">Leukemia, Myeloid, Acute</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
			<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D009154">Mutation</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D018365">Neoplasm, Residual</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D011518">Proto-Oncogene Proteins</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D016019">Survival Analysis</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D014157">Transcription Factors</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D014178">Translocation, Genetic</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D014408">Tumor Markers, Biological</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
	    </MeshHeading>
	</MeshHeadingList>
</root>
